Elevation Pharmaceuticals Obtains $30,000,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b2eacac8-254f-409a-8231-c69cfda3142e&Preview=1 -
Date
1/4/2012 -
Company Name
Elevation Pharmaceuticals -
Mailing Address
11455 El Camino Real San Diego, CA 92130 -
Company Description
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients’ lives. -
Website
http://www.elevationpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The Series B financing will allow Elevation to complete all activities sufficient to initiate Phase 3 studies by the end of 2013. -
M&A Terms
-
Venture Investor
Novo A/S -
Venture Investor
Canaan Partners -
Venture Investor
TPG Biotech -
Venture Investor
Care Capital -
Venture Investor
Mesa Verde Venture Partners
